News About <![CDATA[Johnson & Johnson]]> News About en-us <![CDATA[Investment Ideas in the Expanding Wound Care Market]]> <![CDATA[J&J, Up 25% YTD, Shrugs Off Risperdal Suits]]> <![CDATA[Jennifer Aniston: Movie Star Turned Hair Care Mogul]]> <![CDATA[Midday Movers: DATA, V, ARUN & More]]> <![CDATA[Small Is Beautiful: Now's the Time for Growth-Oriented Investors to Move Into Small-Cap Stocks]]> <![CDATA[4 Pharmaceutical Stocks to Buy Now]]> ]]> <![CDATA[Free Research Reports on DRYS, INFI, JNJ and SCTY Issued by the Bedford Report ]]> <![CDATA[Defensive stocks due for a pullback]]> <![CDATA[Buybacks Are Boosting the Market]]> ]]> <![CDATA[Is SoCalEd Mired In Crisis Or Controversy?]]> <![CDATA[(SNY) Sanofi Earnings Plummet – Outlook Maintained]]>
Visit StockBlogHub to view complete post.]]>
<![CDATA[Notable ETF Inflow Detected - VHT, JNJ, LLY, UNH]]> <![CDATA[GE Healthcare Targets Growth Markets And New Technologies To Drive Sales]]> <![CDATA[X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 23]]> <![CDATA[Don’t Chase Bond Safety With More Risk]]> ]]> <![CDATA[RPT-INSIGHT-Dimon has big say over who serves on JPMorgan board]]> <![CDATA[INSIGHT-Dimon has big say over who serves on JPMorgan board]]> <![CDATA[With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What]]> <![CDATA[(LIFE) MedTech Industry Stock Update – May 2013 – Zacks Analyst Interviews]]>
Visit StockBlogHub to view complete post.]]>
<![CDATA[Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)]]> <![CDATA[Modified Shares in Medical Care Industry : BMY, BSX, MNKD, JNJ]]> New York, NY -- (SBWIRE) -- 05/15/2013 -- Bristol-Myers Squ (NYSE:BMY) is +1.68 - +3.98% from the previous close of $42.21. It traded between $42.16 - 44.26 with total traded volume of 12123759 shares. At Current Market Price, BMY is in distance of +7.67% from its 50-day Moving Average price of $40.7643 and +20.71% from its 200-day Moving Average price of $36.3612.

]]>
<![CDATA[The Straight Truth, Investing in JNJ, MGM, DNDN and AGNC ]]> <![CDATA[StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX]]> <![CDATA[Why I Won’t Sell Dividend Stocks Even After a 1000% Gain]]> ]]> <![CDATA[Inova president: Health systems entering 'new normal' of fewer patients]]> <![CDATA[Health Care Is Hot, but Technology Offers Better Value]]> <![CDATA[XLV, UWM: Big ETF Outflows]]> <![CDATA[Can Merck’s Pipeline Offset The Pain From Major Patent Expirations?]]> <![CDATA[Johnson & Johnson (JNJ) Stock Technical Breakout Alert]]> Bridgewater, MA -- (SBWIRE) -- 05/14/2013 -- The online StockConsultant latest screen has found provider of personal care hygienic products, pharmaceuticals and surgical equipment Johnson & Johnson (NYSE:JNJ) stock with a confirmed breakout above 86.23 to new highs.

]]>
<![CDATA[How to Find: Low-Volatility Stocks, Not Overpriced]]> <![CDATA[Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed]]> <![CDATA[New App Lets You Boycott Koch Brothers, Monsanto And More By Scanning Your Shopping Cart]]> <![CDATA[The Conundrum Of Healthcare In India]]> <![CDATA[RPT-U.S. House panel questions resignation of top FDA official]]> <![CDATA[5 Stocks With Great Earnings Growth — MIL MA MXWL AEGN JNJ]]> ]]> <![CDATA[Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheter]]> <![CDATA[New Data On Boston Scientific’s Atrial Fibrillation ‘Watchman’ Device Could Lift Outlook]]> <![CDATA[NanoPass Technologies Supports a CDC-Sponsored Phase 3 Study of Polio Vaccine in Infants as Part of its Global Health Initiative]]> <![CDATA[Stock Buybacks: We Separate Smart from Dumb]]> <![CDATA[We’re eating more sugar, less Splenda]]> <![CDATA[J&J's (JNJ) Janssen Receives Priority Review from FDA for Simeprevir]]> <![CDATA[A new lineup for the American Heroes portfolio]]> <![CDATA[Short Interest in Vertex Rises, in Celgene Falls]]> The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April.

The number of shares sold short in Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Illumina (NASDAQ: ILMN), Onyx Pharmaceuticals (NASDAQ: ONXX) and VIVUS (NASDAQ:

]]>
<![CDATA[Special Situation Coming Soon, a Look Inside DDD, JNJ, MRK and EXC ]]> <![CDATA[Strategy Behind Our Success, We Get in Early: WMB, AMZN, IBM and JNJ ]]> <![CDATA[J&J: Before We Hand Over That $2.2 Billion . . .]]> <![CDATA[J&J, Ethicon finding growing surgical market in India amid obesity epidemic]]> Johnson & Johnson and its Cincinnati subsidiary, Ethicon Endo-Surgery, are benefiting from growing interest in obesity surgery in India, Bloomberg reports. Although 18 percent of the population is undernourished, economic development is also bringing an onslaught of the diseases of affluence, including diabetes and hypertension. In the largest cities, such as Mumbai, more adult women are now overweight than underweight, according to Bloomberg. The New Brunswick, N.J.-based J&J (NYSE: JNJ) teaches…
]]>
<![CDATA[Stock shorts get hurt, but don’t call it a squeeze]]> <![CDATA[Healthcare Stock Watch List: Affymax, Inc. (NASDAQ:AFFY) and Johnson & Johnson (NYSE:JNJ) Added to Equity Profile Report's Healthcare Stock Watch List.]]> Wilmington, DE -- (SBWIRE) -- 05/10/2013 -- Equity Profile Report expands its Healthcare Stock Weekly Watch List adding Affymax, Inc. (NASDAQ:AFFY) and Johnson & Johnson (NYSE:JNJ).

]]>
<![CDATA[Medtronic: A Look At The Spinal Division]]>